Nightware, Inc.
Company profile
Primary focus
Prescription digital therapeutics for reducing sleep disturbance related to Nightmare Disorder and PTSD-related nightmares.
Why it’s included
The company develops and manufactures an FDA-cleared prescription digital therapeutic system explicitly indicated for PTSD-related nightmares, supported by its own clinical trials, patents, and Department of Defense-funded PTSD research.
Relevant capabilities
- Real-time AI-driven detection of nightmare events with adaptive haptic intervention
- Integration with wearable biometric sensors and mobile devices
- Randomized, double-blind, sham-controlled clinical trial design and execution
- Regulatory submissions and interactions with FDA including Breakthrough Device pathway
- Clinical outcome measurement and clinical data analysis
Commercial sectorDigital Therapeutics, VR Exposure, and Wearable Devices
Technology classesDigital therapeutics for PTSD nightmares
Relevant commercial products
- Prescription digital therapeutic wearable kit for reducing nightmare-related sleep disturbance
- Trauma Related Nightmare Survey
- Nightmare Disorder Index
- Insomnia Severity Index
- Patient Health Questionnaire
Relevant patents
2 families, 5 publications- Traumatic nightmare detection and intervention US-10765831-B1
- Systems and methods for automated stress monitoring and intervention US-12070326-B2